105 related articles for article (PubMed ID: 28249123)
1. Clinical Experience with U-500 Regular Insulin by Multiple Daily Injections and Continuous Subcutaneous Insulin Infusion.
Meade LT; Tart RC; Nuzum D
Diabetes Technol Ther; 2017 Apr; 19(4):220-225. PubMed ID: 28249123
[TBL] [Abstract][Full Text] [Related]
2. Comparison of continuous subcutaneous insulin infusion and multiple daily insulin injections in Chinese patients with type 2 diabetes mellitus.
Yang H; Heng X; Liang C; Liu X; Du W; Li S; Wang Y; Dong Q; Li W; Pan Z; Gong Q; Gao G
J Int Med Res; 2014 Aug; 42(4):1002-10. PubMed ID: 24965335
[TBL] [Abstract][Full Text] [Related]
3. A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.
Herman WH; Ilag LL; Johnson SL; Martin CL; Sinding J; Al Harthi A; Plunkett CD; LaPorte FB; Burke R; Brown MB; Halter JB; Raskin P
Diabetes Care; 2005 Jul; 28(7):1568-73. PubMed ID: 15983302
[TBL] [Abstract][Full Text] [Related]
4. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis.
Ranasinghe PD; Maruthur NM; Nicholson WK; Yeh HC; Brown T; Suh Y; Wilson LM; Nannes EB; Berger Z; Bass EB; Golden SH
J Womens Health (Larchmt); 2015 Mar; 24(3):237-49. PubMed ID: 25713996
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: A Posthoc Analysis.
Hood RC; Chen Y; Sindelar DK; Ly T; Juneja R; Pollom RD; Ilag L; Wysham C
Endocr Pract; 2021 Aug; 27(8):783-789. PubMed ID: 33515757
[TBL] [Abstract][Full Text] [Related]
6. Retrospective analysis and patient satisfaction assessment of insulin pump therapy in patients with type 2 diabetes.
Gentry CK; Cross LB; Gross BN; McFarland MS; Bestermann WH
South Med J; 2011 Jan; 104(1):24-8. PubMed ID: 21079529
[TBL] [Abstract][Full Text] [Related]
7. Clinical use of U-500 regular insulin: review and meta-analysis.
Reutrakul S; Wroblewski K; Brown RL
J Diabetes Sci Technol; 2012 Mar; 6(2):412-20. PubMed ID: 22538155
[TBL] [Abstract][Full Text] [Related]
8. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.
Potti LG; Haines ST
J Am Pharm Assoc (2003); 2009; 49(1):e1-13; quiz e14-7. PubMed ID: 19196588
[TBL] [Abstract][Full Text] [Related]
10. [Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes mellitus].
Hasselmann C; Bonnemaison E; Faure N; Mercat I; Bouillo Pépin-Donat M; Magontier N; Chantepie A; Labarthe F
Arch Pediatr; 2012 Jun; 19(6):593-8. PubMed ID: 22584198
[TBL] [Abstract][Full Text] [Related]
11. Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.
Monami M; Lamanna C; Marchionni N; Mannucci E
Exp Clin Endocrinol Diabetes; 2009 May; 117(5):220-2. PubMed ID: 19301231
[TBL] [Abstract][Full Text] [Related]
12. The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort survey.
Deberles E; Morello R; Hardouin J; Amadou C; Benhamou PY; Prévost G; Schaepelynck P; Chaillous L; Joubert M; Reznik Y
Diabetes Metab; 2022 May; 48(3):101300. PubMed ID: 34728340
[TBL] [Abstract][Full Text] [Related]
13. Insulin pump therapy in adults.
Didangelos T; Iliadis F
Diabetes Res Clin Pract; 2011 Aug; 93 Suppl 1():S109-13. PubMed ID: 21864741
[TBL] [Abstract][Full Text] [Related]
14. [Continuous subcutaneous insulin infusion].
Balsa AM; Neves C; Alves M; Pereira M; Carvalho D; Medina JL
Acta Med Port; 2011 Dec; 24 Suppl 2():147-56. PubMed ID: 22849898
[TBL] [Abstract][Full Text] [Related]
15. Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Roze S; Smith-Palmer J; Valentine WJ; Cook M; Jethwa M; de Portu S; Pickup JC
J Med Econ; 2016; 19(3):236-42. PubMed ID: 26510389
[TBL] [Abstract][Full Text] [Related]
16. Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis.
Lynch P; Riedel AA; Samant N; Fan Y; Peoples T; Levinson J; Lee SW
Prim Care Diabetes; 2010 Dec; 4(4):209-14. PubMed ID: 20832374
[TBL] [Abstract][Full Text] [Related]
17. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up.
Sulli N; Shashaj B
Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629
[TBL] [Abstract][Full Text] [Related]
18. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
[TBL] [Abstract][Full Text] [Related]
19. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
20. Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion.
Pickup JC; Sutton AJ
Diabet Med; 2008 Jul; 25(7):765-74. PubMed ID: 18644063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
